P Bosch, M Bond, C Dejaco, C Ponte, SL Mackie… - RMD open, 2023 - rmdopen.bmj.com
Objectives To update the evidence on imaging for diagnosis, monitoring and outcome prediction in large vessel vasculitis (LVV) to inform the 2023 update of the European …
M Maz, SA Chung, A Abril, CA Langford… - Arthritis & …, 2021 - Wiley Online Library
Objective To provide evidence‐based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large …
C Dejaco, S Ramiro, M Bond, P Bosch… - Annals of the …, 2024 - ard.bmj.com
Objectives To update the EULAR recommendations for the use of imaging modalities in primary large vessel vasculitis (LVV). Methods A systematic literature review update was …
With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with …
White blood cells activated by either a pathogen or as part of a systemic inflammatory disease are characterized by high energy consumption and are therefore taking up the …
Purpose Monitoring disease activity in patients with large vessel vasculitis (LVV) can be challenging.[18F] FDG-PET/CT is increasingly used to evaluate treatment response in LVV …
AM Sammel, E Hsiao, G Schembri… - Arthritis & …, 2019 - Wiley Online Library
Objective Positron emission tomography/computed tomography (PET/CT) has not been well studied as a first‐line test for giant cell arteritis (GCA), due, in part, to historical limitations in …
GCA is the most common form of primary systemic vasculitis affecting older people. It is considered a clinical emergency because it can lead to irreversible blindness in around …
D Camellino, EL Matteson, F Buttgereit… - Nature Reviews …, 2020 - nature.com
Giant cell arteritis (GCA) is the most common type of primary vasculitis in Western countries. Polymyalgia rheumatica (PMR) is the second most common inflammatory rheumatic disease …